Indonesia to Bring in Doctors from Belarus for Specialist Training
The Ministry of Health will bring in doctors from Belarus to train medical personnel in Indonesia. This plan was agreed upon by both nations during a bilateral meeting between Deputy Minister of Health Dante Saksono Habuwosity and the Minister of Health of the Republic of Belarus, Aliaksandr Khajayeu, at the National Brain Centre Hospital Prof. Dr. dr. Mahar Mardjono, Jakarta, on Wednesday, 1 July 2026.
Dante stated that Indonesia’s cooperation with Belarus will focus on the development of medical education and the pharmaceutical sector. In the field of education, Indonesia is exploring fellowship programmes to increase the competence of doctors across several specialist fields.
“We will send a delegation to Belarus to evaluate their programmes, as well as bring doctors from Belarus to Indonesia to provide training to our doctors,” said Dante, as quoted from the Ministry of Health website on Saturday, 4 July 2026.
According to Dante, the training programme will focus on the management of heart disease, cancer, neurology and stroke, urology, nephrology, as well as maternal and child health. He assessed that Belarus possesses experience that can complement the development of Indonesia’s healthcare system.
Furthermore, the two nations, which have maintained bilateral relations for 33 years, will also establish cooperation in the pharmaceutical sector. The Indonesian government is opening opportunities for collaboration between the Belarusian pharmaceutical company, Belpharmprom, and domestic manufacturing industries to expand access to and the distribution of medical devices and pharmaceutical products.
“Tomorrow morning, pharmaceutical companies from Indonesia will hold meetings with their counterparts. The Ministry of Health fully supports this development and will bridge the coordination with pharmaceutical companies from Belarus,” Dante added.
Meanwhile, the Belarusian Minister of Health, Aliaksandr Khajayeu, noted that Indonesia and Belarus share many similarities in regulating the use of generic medicines. This similarity is expected to accelerate the implementation of joint programmes.
“Regarding the areas of cooperation, this is an excellent meeting. Our standards, especially for generic medicines, do not have significant differences. We are ready to welcome specialists directly to accelerate the existing processes,” said Aliaksandr.
As a follow-up to the agreement, the Ministry of Health stated that it has drafted the Operational Roadmap 2026–2030, serving as the operational instrument for this high-level agreement. This roadmap is designed to ensure that various programmes, including the exchange of experts, medical education, and pharmaceutical collaboration, can proceed in a measurable manner and provide benefits to the healthcare systems of both countries.